Mizuho America, INC.
Reporting payments is a legal requirement; large totals often reflect large product portfolios.
$1.6Mgeneral payments (2019-2025)
$0.00research payments (2019-2025)
89clinicians paid
General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.
General payments by year
General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.
Specialties it works with most
Clinicians with the largest reported totals
Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.
| Clinician | Location | Specialty | General payments (2019-2025) |
|---|---|---|---|
| Michael Lawton | Phoenix, AZ | Neurological Surgery | $479,208.38 |
| Daniel Kelly | Santa Monica, CA | Neurological Surgery | $473,025.01 |
| James Evans | Wilmington, DE | Neurological Surgery | $363,830.08 |
| Takanori Fukushima | Raleigh, NC | Neurological Surgery | $74,732.38 |
| Julian Bailes | Evanston, IL | Neurological Surgery | $49,642.34 |
| Steven Giannotta | Los Angeles, CA | Neurological Surgery | $39,914.16 |
| John Day | Little Rock, AR | Neurological Surgery | $39,636.23 |
| Ashraf Youssef | Aurora, CO | Neurological Surgery | $18,011.67 |
| Karol Budohoski | Salt Lake City, UT | Neurological Surgery | $16,155.00 |
| Juan Fernandez-Miranda | Stanford, CA | Neurological Surgery | $7,373.80 |
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.